AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
MediciNova 2025 Q3 Earnings Widening Net Loss of 6.9% as Revenue Flat at $123.3M
Generated by AI AgentDaily EarningsReviewed byRodder Shi
Wednesday, Nov 12, 2025 8:34 pm ET1min read
Aime SummaryMediciNova (MNOV), ranking by market capitalization, reported its fiscal 2025 Q3 earnings on Nov 12th, 2025. The company’s results aligned with expectations, though the widening net loss and flat revenue highlight persistent operational challenges.
Revenue
Total revenue remained flat at $123.3 million for the quarter, showing no growth compared to the previous year.
Earnings/Net Income
MediciNova maintained a stable EPS of -$0.06 in 2025 Q3, consistent with the prior year. However, the company’s net loss expanded to -$3.05 million, a 6.9% increase from -$2.85 million in 2024 Q3. This marks six consecutive years of quarterly losses, underscoring ongoing financial headwinds. The stable EPS of -$0.06 and widened net loss of -$3.05 million underscore ongoing financial challenges, with six consecutive years of quarterly losses.
Price Action
The stock price of
edged down 1.26% during the latest trading day, climbed 3.97% during the most recent full trading week, and surged 26.61% month-to-date.Post-Earnings Price Action Review
The strategy of buying MediciNova (MNOV) shares on the date of quarterly earnings releases and holding for 30 days showed poor performance over the past three years. The cumulative return was -46.8%, significantly underperforming the market, which gained 31.4% over the same period. This indicates that this strategy failed to capitalize on the potential gains in
shares following earnings releases.Additional News
No material non-earnings-related corporate developments were disclosed by MediciNova within the three weeks preceding the Nov 12th, 2025 earnings release. The company did not announce M&A activity, executive leadership changes, or shareholder return programs during the period.
Daily Earnings
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
John Wiley Sons A 2026 Q2 Earnings EPS Surges 13.3% Despite Revenue Decline
Dec.06 2025
Petco Health 2026 Q3 Earnings Profitability Returns with 156.0% Net Income Surge
Dec.06 2025
Signet Jewelers 2026 Q3 Earnings Surpasses Expectations with 185.7% Net Income Growth
Dec.06 2025
Inotiv 2025 Q4 Earnings Narrowed Losses and 15.7% DSA Revenue Growth
Dec.06 2025
Snowflake 2026 Q3 Earnings Narrowed Losses by 11.2% as Revenue Surpasses Estimates
Dec.06 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet